Interdisciplinary Microsystems Group, Department of Mechanical and Aerospace Engineering, University of Florida, PO Box 116250, Gainesville, FL 32611, United States of America.
J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, PO Box 116131, Gainesville, FL 32611, United States of America.
Biomed Mater. 2021 Feb 17;16(2):022005. doi: 10.1088/1748-605X/abde70.
Exosomes contain cargoes of proteins, lipids, micro-ribonucleic acids, and functional messenger RNAs, and they play a key role in cell-to-cell communication and hold valuable information about biological processes such as disease pathology. To harvest their potentials in disease diagnostics, prognostics, and therapeutics, exosome isolation is a crucial first step in providing pure and intact samples for both research and clinical purposes. Unfortunately, conventional methods for exosome separation suffer from low purity, low capture efficiency, long processing time, large sample volume requirement, the need for dedicated equipment and trained personnel, and high cost. In the last decade, microfluidic devices, especially those that incorporate nanostructures, have emerged as superior alternatives for exosome isolation and detection. In this review, we examine microfluidic platforms, dividing them into six categories based on their capture mechanisms: passive-structure-based affinity, immunomagnetic-based affinity, filtration, acoustofluidics, electrokinetics, and optofluidics. Here, we start out exploring the research and clinical needs that translate into important performance parameters for new exosome isolation designs. Then, we briefly introduce the conventional methods and discuss how their failure to meet those performance standards sparks an intense interest in microfluidic device innovations. The essence of this review is to lead an in-depth discussion on not only the technicality of those microfluidic platforms, but also their strengths and weaknesses with regards to the performance parameters set forth. To close the conversation, we call for the inclusion of exosome confirmation and contamination evaluation as part of future device development and performance assessment process, so that collectively, efforts towards microfluidics and nanotechnology for exosome isolation and analysis may soon see the light of real-world applications.
外泌体包含蛋白质、脂质、微核糖核酸和功能性信使 RNA 等货物,在细胞间通讯中发挥着关键作用,并包含有关疾病病理等生物过程的有价值信息。为了挖掘外泌体在疾病诊断、预后和治疗中的潜力,外泌体分离是提供用于研究和临床目的的纯净和完整样本的关键第一步。不幸的是,外泌体分离的传统方法存在纯度低、捕获效率低、处理时间长、样品体积要求大、需要专用设备和经过培训的人员以及成本高的问题。在过去的十年中,微流控装置,特别是那些结合纳米结构的微流控装置,已成为外泌体分离和检测的优越替代品。在这篇综述中,我们检查了微流控平台,根据它们的捕获机制将它们分为六类:基于被动结构的亲和力、基于免疫磁珠的亲和力、过滤、声流、电泳和光流。在这里,我们首先探讨了转化为新的外泌体分离设计的重要性能参数的研究和临床需求。然后,我们简要介绍了传统方法,并讨论了它们未能满足这些性能标准如何激发对微流控器件创新的强烈兴趣。这篇综述的本质是不仅深入讨论这些微流控平台的技术,还讨论它们在设定的性能参数方面的优缺点。最后,我们呼吁将外泌体确认和污染评估纳入未来设备开发和性能评估过程中,以便共同努力将微流控和纳米技术用于外泌体分离和分析,很快就会看到实际应用的曙光。